Medicare Enrolled

Dr. Stephen Bookbinder, M.D.

Rheumatology · Ocala, FL
3210 SW 33RD RD, Ocala, FL 34474
3522377171
Registered in NPPES since 2005
NPI: 1699767202 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Bookbinder from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bookbinder? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Bookbinder

Dr. Stephen Bookbinder is a rheumatology specialist in Ocala, FL, with 21 years of NPI registration.

Between the years covered by Open Payments, Dr. Bookbinder received a total of $7,782 from 30 pharmaceutical and/or device companies across 533 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Bookbinder is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 21 years of NPI registration $7,782 industry payments

Industry Payment Transparency

Open Payments through 2022 ↗
$7,782
Total received (2018-2022)
Avg $1,556/year across 5 years
Top 47% in FL for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
30
Companies
533
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2022
$1,554
2021
$1,450
2020
$1,627
2019
$1,882
2018
$1,269

Payments by company (2022)

ABBVIE INC.
$440
Janssen Biotech, Inc.
$308
Amgen Inc.
$148
UCB, Inc.
$144
Horizon Therapeutics plc
$117
AstraZeneca Pharmaceuticals LP
$112
PFIZER INC.
$108
GlaxoSmithKline, LLC.
$58
Novartis Pharmaceuticals Corporation
$47
Boehringer Ingelheim Pharmaceuticals, Inc.
$39
Radius Health, Inc.
$32
Top 3 companies account for 57.7% of 2022 payments
All-time payments by company (2018-2022) ›
Amgen Inc.
$1,287
UCB, Inc.
$802
Janssen Biotech, Inc.
$731
PFIZER INC.
$561
AbbVie Inc.
$545
AbbVie, Inc.
$541
E.R. Squibb & Sons, L.L.C.
$452
Horizon Therapeutics plc
$444
ABBVIE INC.
$440
Novartis Pharmaceuticals Corporation
$399
Genentech USA, Inc.
$345
GENZYME CORPORATION
$326
GlaxoSmithKline, LLC.
$195
Boehringer Ingelheim Pharmaceuticals, Inc.
$118
AstraZeneca Pharmaceuticals LP
$112
Radius Health, Inc.
$79
Mallinckrodt Hospital Products Inc.
$70
Lilly USA, LLC
$54
Janssen Pharmaceuticals, Inc
$49
Sobi, Inc
$42
SOBI, INC
$35
Bioventus LLC
$28
Horizon Pharma plc
$26
Actelion Pharmaceuticals US, Inc.
$18
Mallinckrodt LLC
$18
TerSera Therapeutics LLC
$17
Celgene Corporation
$16
Eisai Inc.
$12
West-Ward Pharmaceuticals
$12
Organon LLC
$8
Top 3 companies account for 36.2% of all-time payments
Associated products mentioned in payments ›
ACTHAR · Actemra · BENLYSTA · COSENTYX · Cimzia · Dayvigo · Durolane · EVENITY · Enbrel · GELSYN-3 · HUMIRA · Humira · INFLECTRA · KEVZARA · KINERET · KRYSTEXXA · Kineret · Mitigare · OFEV · OPSUMIT MACITENTAN · ORENCIA · Otezla · Prolia · Quzyttir · RAYOS · REMICADE · RINVOQ · Rinvoq · Rituxan · SAPHNELO · SIMPONI ARIA · SKYRIZI · TALTZ · TREMFYA · Tymlos · XELJANZ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a rheumatology specialist in Ocala?
Compare rheumatologists in the Ocala area by procedure volume, costs, and industry payment transparency.
Browse rheumatologists nearby

Geographic Context

Rheumatologists in nearby ZIP areas
2
County median income
$58,535
Nearest hospital to ZIP centroid (approximate)
ADVENTHEALTH OCALA
0.0 mi

Data Sources

Provider Registry ✓ NPPES NPPES snapshot; verify current record
Medicare Enrollment ✓ PECOS PECOS snapshot
Practice Data — No data N/A
Industry Payments ✓ Open Payments CY 2022
Disciplinary History — Not included N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Bookbinder is a rheumatology specialist, with 21 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Bookbinder receive payments from pharmaceutical companies?
Yes. Dr. Bookbinder received a total of $7,782 from 30 companies across 533 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Bookbinder) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →

Explore related providers

Same specialty & city
Rheumatologists in Ocala
Browse rheumatologists in Ocala ranked by procedure volume and transparency data.
Highest volume
Top Rheumatologists in FL
Rheumatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Rheumatologists in FL
Which FL rheumatologists receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →